{"filing":{"accession_number":"0001213900-26-090065","cik":"0001584371","ticker":"ICCM","company_name":"IceCure Medical Ltd.","form":"6-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"ea030144302-6k_icecure.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026090065/ea030144302-6k_icecure.htm"},"events":[{"id":27900,"run_id":25477,"accession_number":"0001213900-26-090065","anchor_item_number":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"On August 11, 2026, the Board approved an increase of 2,500,000 ordinary shares reserved for issuance under the Company's 2024 Employee Equity Incentive Plan, raising the total from 112,667 to 2,612,667 shares. This is a material amendment to the equity compensation plan that expands the pool available for employee grants and would affect investor assessment of dilution and executive/employee compensation arrangements.","company_name":"IceCure Medical Ltd.","ticker":"ICCM","filing_date":"2026-08-14","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":29614,"accession_number":"0001213900-26-090065","item_number":null,"item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"On August 11, 2026, the Board approved an increase of 2,500,000 ordinary shares reserved for issuance under the Company's 2024 Employee Equity Incentive Plan, raising the total from 112,667 to 2,612,667 shares. This is a material amendment to the equity compensation plan that expands the pool available for employee grants and would affect investor assessment of dilution and executive/employee compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:21:59.245386+00:00","company_name":"IceCure Medical Ltd.","ticker":"ICCM","filing_date":"2026-08-14"}]}